The clinical utility of C-peptide measurement in the care of patients with diabetes
about
Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literatureSpatiotemporal Dynamics of Insulitis in Human Type 1 DiabetesThe effect of insulin administration on c-peptide in critically ill patients with type 2 diabetesA Practical Review of C-Peptide Testing in DiabetesUrinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.Association of insulin-related serum factors with colorectal polyp number and type in adult males.Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women.Subclinical Diabetes.Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORDAssociation between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetesPersonalized medicine in diabetes mellitus: current opportunities and future prospectsAnti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.Differential effects of prenatal stress on metabolic programming in diet-induced obese and dietary-resistant ratsImpacts of the Great East Japan Earthquake on diabetic patients.Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in KoreaPlasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humansClinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013.Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.Baseline-Corrected QT (QTc) Interval Is Associated with Prolongation of QTc during Severe Hypoglycemia in Patients with Type 2 Diabetes MellitusTestosterone supplementation improves glucose homeostasis despite increasing hepatic insulin resistance in male mouse model of type 2 diabetes mellitus.Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion.Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetesMicrofluidic perfusion systems for secretion fingerprint analysis of pancreatic islets: applications, challenges and opportunities.Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells.An update on the potential role of C-peptide in diabetes and osteoporosis.Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?CancerPDF: A repository of cancer-associated peptidome found in human biofluids.Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.An assessment of the impact of type 2 diabetes on the quality of life based on age at diabetes diagnosis.Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle.Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach.The Role of Laboratory Testing in Differentiating Type 1 Diabetes from Type 2 Diabetes in Patients Undergoing Bariatric Surgery.Close correlation between the ankle-brachial index and symptoms of depression in hemodialysis patients.Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study)Direct comparison of radioimmunoassay and LC-MS/MS for PK assessment of insulin glargine in clinical development.Effect of C-peptide Alone or in Combination with Nicotinamide on Insulin Levels from Pancreatic Islets in Mouse.
P2860
Q28607704-45157AC2-0BD0-4C70-B931-A48DDD535F9EQ30833054-AF909A75-E4F3-4E64-876B-6ED724AAA733Q33665256-A25E8531-2E6C-4B07-BE84-5C25C2D20AFCQ33732640-29D502FD-E848-47D7-B67F-5DA7B702C0F1Q34131203-C0D2A972-CE73-4862-BB9D-1279BFE18424Q34135535-FA16BE02-B26A-46CD-9998-09DC5C50C06CQ34139727-87D46ADF-A92D-48F5-BCF2-E412BFE97983Q34556500-67FE7B41-4AB4-44D0-955D-E3F67E2E33C0Q35561497-CA690498-3AC1-4876-AB35-6DD5F2A23C61Q35597894-A707815E-318D-4068-A75C-1CA0F182EAB1Q35779453-3691234B-A0C7-4FF7-9BB1-4167A2BD2FAEQ35895011-6B835B2E-5E85-4BB4-8219-70A7DE8BBA00Q36066581-73FC4841-CFB8-44FE-BF4F-9ED2A8067E6EQ36082267-2238BCA4-B6D4-412A-950E-8528FAAFD388Q36239494-86C24C96-6643-42BE-BEFC-14CA95CCC3AFQ36271971-A05B0BC0-9008-4B7B-A12E-79316C860B0BQ36314713-DB6BE43A-C450-4E28-BC16-80004775E9AFQ36548007-7E63C97C-09C6-42B1-AC6D-1D7468DC9AF2Q36972891-C8ED426B-D67A-4E57-84DE-80B5D5A97AD7Q37516039-04479938-56C6-45C0-B65B-E0F091E088D8Q37575890-92A03567-CB96-4D06-A0C1-1F669352311EQ37576692-E37D6250-5DCE-4BF1-9958-C9FFE3F8617AQ37622457-21323A2F-1433-4CEC-BD7C-DD39E3D0B3EBQ38687419-AB2B0F20-4D99-4254-9643-0D43AEE92338Q38701664-913DC94C-2B08-4250-BDFA-DA685360EF84Q38735225-3770E49D-151A-4426-B8BE-8A565089964BQ38735440-5FD89CFC-666C-40A0-9E93-E7CF36CD2757Q38769343-6D89C5AA-78F3-482A-8922-232B0F7A8C16Q38803215-47889F34-06BB-45AA-9099-331A1C368231Q39007804-019E9BBF-40BF-4DF8-95B3-E6EACF7F1519Q39104797-57AF5633-44EB-41D3-9B57-FB756493DE9BQ39208004-9F35B00B-E043-48CE-B889-29AB77E60D5BQ40109903-345D58B1-F80C-48A0-9CA4-AA2D48C93B28Q40127909-D5D7D69C-C3C6-4071-B628-C778BEFB84A1Q40232971-8BA7022C-24F8-490B-88B0-C213EB0DB392Q41251582-25D3744E-88FD-44A6-A041-0307CCC798DEQ41513696-8A28A42D-DEC4-49D7-B29A-F252CAD54B5FQ41540115-F8E7BBBE-15AB-4CD3-B2CB-C2485001B4D9Q41656524-978F792A-4377-4E9B-880F-859FF3C95925Q41898092-19B9A110-7CC4-41EB-A327-955B55B52D33
P2860
The clinical utility of C-peptide measurement in the care of patients with diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical utility of C-peptide measurement in the care of patients with diabetes
@en
The clinical utility of C-peptide measurement in the care of patients with diabetes.
@nl
type
label
The clinical utility of C-peptide measurement in the care of patients with diabetes
@en
The clinical utility of C-peptide measurement in the care of patients with diabetes.
@nl
prefLabel
The clinical utility of C-peptide measurement in the care of patients with diabetes
@en
The clinical utility of C-peptide measurement in the care of patients with diabetes.
@nl
P2860
P921
P356
P1433
P1476
The clinical utility of C-peptide measurement in the care of patients with diabetes
@en
P2093
A T Hattersley
P2860
P304
P356
10.1111/DME.12159
P5008
P577
2013-07-01T00:00:00Z